Authors:
Lark, MW
Stroup, GB
Dodds, RA
Kapadia, R
Hoffman, SJ
Hwang, SM
James, IE
Lechowska, B
Liang, XG
Rieman, DJ
Salyers, KL
Ward, K
Smith, BR
Miller, WH
Huffman, WF
Gowen, M
Citation: Mw. Lark et al., Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat, J BONE MIN, 16(2), 2001, pp. 319-327
Authors:
Badger, AM
Blake, S
Kapadia, R
Sarkar, S
Levin, J
Swift, BA
Hoffman, SJ
Stroup, GB
Miller, WH
Gowen, M
Lark, MW
Citation: Am. Badger et al., Disease-modifying activity of SB 273005, an orally active, nonpeptide alpha(v)beta(3) (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis, ARTH RHEUM, 44(1), 2001, pp. 128-137
Authors:
Badger, AM
Griswold, DE
Kapadia, R
Blake, S
Swift, BA
Hoffman, SJ
Stroup, GB
Webb, E
Rieman, DJ
Gowen, M
Boehm, JC
Adams, JL
Lee, JC
Citation: Am. Badger et al., Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis, ARTH RHEUM, 43(1), 2000, pp. 175-183
Citation: R. Kapadia et al., Binding of the renal epithelial cell line LLC-PK1 to laminin is regulated by protein kinase C, J AM S NEPH, 10(6), 1999, pp. 1214-1223
Authors:
Gowen, M
Lazner, F
Dodds, R
Kapadia, R
Feild, J
Tavaria, M
Bertoncello, I
Drake, F
Zavarselk, S
Tellis, I
Hertzog, P
Debouck, C
Kola, I
Citation: M. Gowen et al., Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrixdegradation but not demineralization, J BONE MIN, 14(10), 1999, pp. 1654-1663